The psychosocial burden of psoriasis: addressing mental health, societal stigma, and disparities in marginalized populations

Sahil Kapur; Kermanjot Sidhu; Sajan Shah; Bryce DeLong; Craig G. Burkhart

doi:10.18203/issn.2455-4529.IntJResDermatol20252079

Authors

Sahil Kapur Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA
Kermanjot Sidhu Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA
Sajan Shah University of Toledo, Toledo, Ohio, USA
Bryce DeLong Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA
Craig G. Burkhart Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252079

Keywords:

Psoriasis, Psychological, Depression, Dermatology quality of life index

Abstract

Psoriasis is a chronic inflammatory skin condition that has a 2-3% global prevalence and imposes a significant psychosocial burden. The pathogenesis of psoriasis involves a complex interplay of genetic, environmental, and immunological factors. Current clinical management often focuses on its visible and systemic manifestations and remains limited in capturing the environmental component.

Metrics

Metrics Loading ...

References

Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85. DOI: https://doi.org/10.1038/jid.2012.339

Jalenques I, Bourlot F, Martinez E, Pereira B, D'Incan M, Lauron S, et al. Prevalence and odds of anxiety disorders and anxiety symptoms in children and adults with psoriasis: systematic review and meta-analysis. Acta Derm Venereol. 2022;102:769. DOI: https://doi.org/10.2340/actadv.v102.1386

National Institute of Mental Health. Social anxiety disorder. Bethesda (MD): National Institute of Mental Health; 2021. Available at: https://www.nimh.nih.gov. Accessed on 22 January 2025.

Peterson H, Huang MY, Lee K, Kingston P, Yee D, Korouri E, et al. Comorbidity burden in psoriasis patients with skin of color. J Psoria Psor Arthritis. 2024;9(1):16-22. DOI: https://doi.org/10.1177/24755303231198482

Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002;146(3):458-65. DOI: https://doi.org/10.1046/j.1365-2133.2002.04622.x